“…The emergence of multidrug-resistant pathogens worldwide as well as a lack of new drug development is a concern in both human and veterinary medicine (CDC, 2013;Ventola, 2015). Research studies show that there is bacterial resistance to biocides (Davin-Regli & Pagès, 2012;Maillard, 2007;Russell, 2002;Slipski, Zhanel, & Bay, 2018;Tumah, 2009), and biocide use has resulted in cross-resistance to antimicrobials (Al-Jailawi, Ameen, & Al-Jeboori, 2013;Beier, Bischoff, Ziprin, Poole, & Nisbet, 2005;Braoudaki & Hilton, 2004;Davin-Regli & Pagès, 2012;Gnanadhas, Marathe, & Chakravortty, 2013;Maris, 1991;Romaro, Burgos, Pérez-Pulido, Gálvez, & Lucas, 2017;Sidhu, Heir, Leegaard, Wiger, & Holck, 2002;Wales & Davies, 2015;Wand, Bock, Bonney, & Sutton, 2017) producing a real risk that increased biocide use may exacerbate the trend of increasing AMR in pathogenic organisms (Fraise, 2002).…”